Ticker,Title,Link
KURA,"Analysts Offer Insights on Healthcare Companies: Tourmaline Bio (TRML), Amicus (FOLD) and Kura Oncology (KURA)",8/13/2024 3:11:44 PM
KURA,Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA) and Aquestive Therapeutics (AQST),8/12/2024 4:30:49 AM
KURA,Kura Oncology (KURA) Gets a Buy from Stifel Nicolaus,8/9/2024 1:19:28 PM
KURA,Kura Oncology Reports Second Quarter 2024 Financial Results,8/8/2024 10:05:00 PM
KURA,Kura Oncology Q2 2024 Earnings Preview,8/7/2024 9:35:53 PM
KURA,Kura Oncology to Report Second Quarter 2024 Financial Results,8/1/2024 1:30:00 PM
KURA,7 ‘Death Cross’ Stocks That Could Be Contrarian Buys,7/17/2024 6:29:27 PM
KURA,Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),7/5/2024 1:30:00 PM
KURA,Barclays Remains a Buy on Kura Oncology (KURA),6/28/2024 9:30:21 AM
KURA,Kura Oncology’s Ziftomenib: A Promising and Potentially Safer Treatment for Type 2 Diabetes,6/25/2024 10:09:40 AM
KURA,Buy Recommendation for KURA Amidst Promising Ziftomenib Data for Type 2 Diabetes Treatment,6/24/2024 3:25:36 PM
KURA,Buy Rating Affirmed on Kura Oncology Amid Promising Clinical Trials and Strong Financials,6/18/2024 4:25:20 AM
KURA,Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA) and HCA Healthcare (HCA),6/13/2024 1:30:32 PM
KURA,Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),6/7/2024 1:30:00 PM
KURA,Kura Oncology to Participate in Jefferies Global Healthcare Conference,5/29/2024 1:30:00 PM
KURA,Buy Rating Affirmed for Kura Oncology Amidst Positive Developments and Strong Trial Progress,5/16/2024 9:55:46 AM
KURA,Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA) and Tourmaline Bio (TRML),5/14/2024 1:50:07 PM
KURA,Kura Oncology to Participate in Bank of America Securities Healthcare Conference,5/8/2024 1:30:00 PM
KURA,"Analysts Are Bullish on These Healthcare Stocks: Relay Therapeutics (RLAY), Kura Oncology (KURA)",5/6/2024 4:30:43 AM
KURA,"Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Kura Oncology (KURA) and Amgen (AMGN)",5/3/2024 3:34:15 PM
KURA,Kura Oncology Reports First Quarter 2024 Financial Results,5/2/2024 10:05:00 PM
KURA,Notable earnings after Thursday's close,5/1/2024 9:35:20 PM
KURA,Kura Oncology to Report First Quarter 2024 Financial Results,4/25/2024 1:30:00 PM
KURA,Kura Oncology Gets FDA Breakthrough Therapy Designation For Ziftomenib In R/R NPM1-Mutant AML ,4/22/2024 2:29:35 PM
KURA,Kura Oncology to Participate in Stifel Targeted Oncology Forum,4/10/2024 1:30:00 PM
KURA,Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),4/5/2024 1:30:00 PM
KURA,"MGNX, SBNY and SLP are among after hour movers",4/3/2024 9:24:42 PM
KURA,Cantor sees strong year ahead for oncology M&A,3/10/2024 5:08:00 PM
KURA,Buy Rating Affirmed: Kura Oncology’s KO-2806 Shows Promising Clinical and Market Potential,3/6/2024 4:35:19 PM
KURA,Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),3/1/2024 11:00:00 PM
KURA,"Analysts Are Bullish on These Healthcare Stocks: Kura Oncology (KURA), uniQure (QURE)",2/28/2024 3:20:11 PM
KURA,Kura Oncology Reports Fourth Quarter and Full Year 2023 Financial Results,2/27/2024 10:01:00 PM
KURA,Kura Oncology FY 2023 Earnings Preview,2/26/2024 10:35:38 PM
KURA,Kura Oncology to Participate in Three Upcoming Investor Conferences,2/22/2024 1:30:00 PM
KURA,Kura Oncology to Report Fourth Quarter and Full Year 2023 Financial Results,2/20/2024 1:30:00 PM
KURA,Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),2/2/2024 1:30:00 PM
KURA,"3 Best Stocks to Buy Now, 2/1/2024, According to Top Analysts ",2/1/2024 11:01:02 AM
KURA,"Analysts Offer Insights on Healthcare Companies: Option Care Health (OPCH), Alnylam Pharma (ALNY) and Kura Oncology (KURA)",1/31/2024 2:30:25 PM
KURA,Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session,1/30/2024 7:18:28 PM
KURA,Wall Street Analysts Are Bullish on Top Healthcare Picks,1/25/2024 1:10:55 PM
KURA,Dow Edges Lower; US Composite PMI Rises In January,1/24/2024 9:46:29 PM
KURA,"Analysts Offer Insights on Healthcare Companies: MaxCyte (GB:MXCT), Kura Oncology (KURA) and InMode (INMD)",1/23/2024 9:09:10 AM
KURA,Kura Oncology (KURA) Receives a Buy from BTIG,1/7/2024 10:39:46 AM
KURA,"Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA), Gossamer Bio (GOSS) and 4D Molecular Therapeutics (FDMT)",1/4/2024 12:21:07 PM
KURA,BTIG Sticks to Its Buy Rating for Kura Oncology (KURA),1/2/2024 2:29:28 PM
KURA,Clinical Advancements In Kura Oncology's Lead Program Ziftomenib Hint at Upsurge in Success Likelihood: Analyst,12/22/2023 6:50:46 PM
KURA,Buy Rating on Kura Oncology’s Stock: Promising Trials and Strong Cash Position Signal Upside Potential,12/20/2023 5:26:22 AM
KURA,Buy Rating Reaffirmed for Kura Oncology as Ziftomenib Shows Competitive Edge in Phase II Trial,12/13/2023 6:20:22 AM
KURA,"Analysts’ Top Healthcare Picks: Kura Oncology (KURA), Arcellx Inc (ACLX)",12/11/2023 2:50:33 AM
KURA,Positive Buy Rating for Kura Oncology Amid Strategic Alliances and Promising Clinical Trials,12/8/2023 2:35:35 PM
KURA,Kura Oncology to Participate in the JMP Securities Hematology and Oncology Summit,11/28/2023 1:30:00 PM
KURA,"Analysts Are Bullish on Top Healthcare Stocks: Kura Oncology (KURA), Steris (STE)",11/9/2023 5:40:09 AM
KURA,Promising Advancements in Kura Oncology’s Drug Pipeline and Stable Financial Position Bolster Buy Recommendation,11/6/2023 6:07:53 AM
KURA,Scotiabank Reaffirms Their Hold Rating on Kura Oncology (KURA),11/3/2023 12:31:13 PM
KURA,Promising Developments in Kura Oncology’s Treatment Pipeline Bolster ‘Buy’ Recommendation,10/24/2023 12:47:46 PM
KURA,Promising Clinical Trials and Underappreciated FTI Pipeline Justify Buy Rating for Kura Oncology,10/20/2023 10:27:29 AM
KURA,Kura Oncology's Head & Neck Cancer Candidate Shows Meaningful Antitumor Activity In Pretreated Patients,10/18/2023 5:12:36 PM
KURA,"Analysts Are Bullish on These Healthcare Stocks: Lantheus (LNTH), Kura Oncology (KURA)",10/3/2023 1:50:39 PM
KURA,Promising Clinical Trials and Menin Inhibition Potential Drive Buy Rating for Kura Oncology,10/2/2023 3:25:30 PM
KURA,Potential Upswing for Kura Oncology Stock: Promising Preclinical Data and Synergy of KO-2806 Highlighted,10/1/2023 11:35:48 AM
KURA,"Analysts Are Bullish on These Healthcare Stocks: Virpax Pharmaceuticals (VRPX), Kura Oncology (KURA)",9/28/2023 4:10:51 PM
KURA,Analyst Expectations for Kura Oncology's Future,9/7/2023 8:00:48 PM
KURA,"BofA starts Kura at buy, cites revenue potential of lead drug ziftomenib",8/11/2023 6:55:42 PM
KURA,JMP Securities Sticks to Its Buy Rating for Kura Oncology (KURA),8/7/2023 1:05:36 PM
KURA,"Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday",8/4/2023 4:32:24 PM
KURA,Kura Oncology GAAP EPS of -$0.53 beats by $0.01,8/3/2023 8:53:20 PM
KURA,"Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023",7/27/2023 5:00:41 PM
KURA,Where Kura Oncology Stands With Analysts,7/21/2023 4:00:50 PM
KURA,Over $27M Bet On Zymeworks? Check Out These 3 Stocks Insiders Are Buying,6/22/2023 1:16:54 PM
KURA,Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session,6/14/2023 7:12:22 PM
KURA,Kura Oncology plans for $100M stock and warrants offering,6/13/2023 8:12:59 PM
KURA,Analyst Ratings for Kura Oncology,6/12/2023 4:03:49 PM
KURA,Kura Oncology (KURA) Receives a Buy from Stifel Nicolaus,6/7/2023 2:06:43 AM
KURA,Over 100% Upside: Analysts See an Appealing Entry Point in These 2 Small Cap Stocks,6/6/2023 12:02:01 AM
KURA,SVB Securities Sticks to Its Buy Rating for Kura Oncology (KURA),6/3/2023 12:56:17 PM
KURA,"Analysts Are Bullish on These Healthcare Stocks: Kura Oncology (KURA), Siemens Healthineers AG (SEMHF)",6/2/2023 8:50:32 AM
KURA,Kura Oncology (KURA) Gets a Buy from Stifel Nicolaus,5/30/2023 2:07:06 AM
KURA,Stifel Nicolaus Sticks to Its Buy Rating for Kura Oncology (KURA),5/25/2023 2:06:56 AM
KURA,"Benzinga's Top Ratings Upgrades, Downgrades For May 17, 2023",5/17/2023 5:00:49 PM
KURA,JMP Securities Remains a Buy on Kura Oncology (KURA),5/12/2023 4:25:11 AM
KURA,SVB Securities Sticks to Its Buy Rating for Kura Oncology (KURA),5/11/2023 4:46:35 PM
KURA,Kura Oncology GAAP EPS of -$0.50 beats by $0.04,5/10/2023 8:34:08 PM
KURA,Kura Oncology Q1 2023 Earnings Preview,5/9/2023 9:35:49 PM
KURA,3 Under-the-Radar Stocks That AI Predicts Will Soar in May,5/1/2023 6:07:12 PM
KURA,"Catalyst watch: Earnings blitz, Mobileye lockup expiration and the new one-day VIX debut",4/21/2023 7:00:36 PM
KURA,"Analysts Offer Insights on Healthcare Companies: UnitedHealth (UNH), Kura Oncology (KURA) and Ardelyx (ARDX)",4/17/2023 4:40:31 PM
KURA,SVB Securities Sticks to Its Buy Rating for Kura Oncology (KURA),3/28/2023 10:05:42 AM
KURA,"First Majestic Silver, Immatics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session",3/21/2023 11:45:55 AM
KURA,Wedbush Sticks to Its Buy Rating for Kura Oncology (KURA),3/1/2023 12:25:49 PM
KURA,Kura Oncology (KURA) Gets a Buy from SVB Securities,2/24/2023 6:45:07 PM
KURA,Kura Oncology GAAP EPS of -$0.49 beats by $0.08,2/23/2023 9:23:45 PM
KURA,Notable earnings after Thursday's close,2/22/2023 10:35:18 PM
KURA,7 Undiscovered Stocks to Watch for the Next Big Thing,2/12/2023 12:14:03 PM
KURA,H.C. Wainwright Sticks to Its Buy Rating for Kura Oncology (KURA),2/10/2023 11:55:25 AM
KURA,Brookline Capital Markets Sticks to Their Buy Rating for Kura Oncology (KURA),2/9/2023 3:45:04 PM
KURA,2 “Strong Buy” Small Cap Stocks That Can Rip Higher in 2023,1/31/2023 10:43:49 PM
KURA,H.C. Wainwright Keeps Their Buy Rating on Kura Oncology (KURA),1/24/2023 3:05:12 PM
KURA,Kura Oncology (KURA) Receives a Buy from Jefferies,1/18/2023 1:15:29 PM
KURA,"SGMO, CDNS and HOLX are among after hour movers",1/13/2023 10:58:33 PM
KURA,Cramer Is Holding This Biotech Stock,1/12/2023 3:16:54 PM
KURA,Kura Oncology (KURA) Receives a Buy from Brookline Capital Markets,1/2/2023 10:15:08 PM
KURA,SVB Securities Sticks to Its Buy Rating for Kura Oncology (KURA),12/14/2022 3:55:29 AM
KURA,"Kura Oncology falls, Syndax gains after Phase 1/2 data for leukemia candidates",12/12/2022 6:34:01 PM
KURA,Kura Oncology (KURA) Receives a Buy from Brookline Capital Markets,12/11/2022 4:05:08 AM
KURA,"Analysts Are Bullish on These Healthcare Stocks: Altimmune (ALT), Kura Oncology (KURA)",11/8/2022 5:41:22 AM
KURA,SVB Securities Sticks to Its Buy Rating for Kura Oncology (KURA),11/7/2022 3:25:53 AM
KURA,Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA) and Editas Medicine (EDIT),11/4/2022 1:21:46 AM
KURA,"Analysts Are Bullish on Top Healthcare Stocks: Madrigal Pharmaceuticals (MDGL), Kura Oncology (KURA)",11/3/2022 4:20:25 PM
KURA,Kura Oncology Q3 2022 Earnings Preview,11/2/2022 4:33:59 PM
KURA,Kura Oncology (KURA) Gets a Buy from Brookline Capital Markets,10/26/2022 10:55:38 PM
KURA,"Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session",9/30/2022 6:06:41 PM
KURA,"BYND, BILI and KURA are among after hour movers",8/17/2022 9:30:00 PM
KURA,7 Cheap Biotech Stocks to Buy Now,8/3/2022 8:42:38 PM
KURA,Notable earnings after Wednesday's close (updated),8/2/2022 9:35:54 PM
KURA,Read Why Did Credit Suisse Raise Price Target On Kura Oncology,7/13/2022 9:05:59 PM
KURA,"Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022",7/12/2022 4:21:18 PM
KURA,"CNDT, AVPT and FFIE are among after hourmovers",7/11/2022 9:33:01 PM
KURA,PreMarket Prep: Looking For Biotech Bargains With This Wedbush Analyst,5/25/2022 8:40:33 PM
KURA,Kura Oncology GAAP EPS of -$0.49 beats by $0.03,5/4/2022 8:28:49 PM
KURA,Notable earnings after Wednesday's close,5/3/2022 9:35:38 PM
KURA,"The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More",4/13/2022 2:15:54 PM
KURA,"The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More",4/10/2022 10:42:49 PM
KURA,Kura Oncology GAAP EPS of -$0.49 beats by $0.05,2/24/2022 9:26:44 PM
KURA,Notable earnings after Thursday's close,2/23/2022 10:35:44 PM
KURA,"Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2022",2/15/2022 4:02:49 PM
KURA,Kura Oncology CFO Marc Grasso to step down,2/1/2022 9:12:21 PM
KURA,"The Daily Biotech Pulse: Kura Lifts Clinical Hold On Blood Cancer Trial, Intuitive Surgical Earnings, Sorrento's Omicron Antibody Treatment Effective",1/21/2022 2:08:18 PM
KURA,FDA lifts partial clinical hold from Kura Oncology's blood cancer study,1/20/2022 9:11:46 PM
KURA,Kura Oncology doses first patient in mid-stage tipifarnib + alpelisib study in head/neck cancer,12/16/2021 2:58:56 PM
KURA,"The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More",12/6/2021 12:07:24 PM
KURA,Travel and leisure stocks recover as Omicron anxiety fades,11/29/2021 3:04:00 PM
KURA,68 Biggest Movers From Wednesday,11/26/2021 11:41:56 AM
KURA,40 Stocks Moving In Wednesday's Mid-Day Session,11/24/2021 6:00:10 PM
KURA,Kura Oncology EPS beats by $0.04,11/4/2021 8:40:44 PM
KURA,"The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline",10/31/2021 7:23:54 PM
KURA,"Small biotechs warn Biden, lawmakers on drug price bill impact on R&D",9/8/2021 9:55:22 PM
KURA,"Jon Najarian Sees Unusual Options Activity In Lucid Motors, Kura Oncology And More",8/24/2021 11:05:35 PM
KURA,"The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data",8/20/2021 1:45:43 PM
KURA,"The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline",8/18/2021 1:37:56 PM
KURA,"The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business",8/17/2021 2:28:53 PM
KURA,"The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma",8/12/2021 2:09:26 PM
KURA,"The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering",8/11/2021 2:14:38 PM
KURA,"The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts",8/10/2021 1:55:36 PM
KURA,Kura Oncology EPS misses by $0.02,8/5/2021 8:13:29 PM
KURA,"The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs",8/1/2021 4:13:48 PM
KURA,Kura Oncology adds Helen Collins to board of directors,7/29/2021 1:26:40 PM
KURA,Kura Oncology teams up with Novartis for head and neck squamous cell carcinoma study,7/6/2021 11:41:56 AM
KURA,Kura Oncology doses first patient in early-stage KO-539 leukemia study,6/24/2021 12:41:02 PM
KURA,"The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom",5/6/2021 1:49:39 PM
KURA,Kura Oncology Inc hosts conference call for investors,5/5/2021 3:01:47 PM
KURA,"Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge",5/1/2021 7:19:25 PM
KURA,"GURE, ASO, PRVB and WDFC among after-hours movers",4/8/2021 9:40:54 PM
KURA,Potbelly and Shake Shack lead restaurant sector higher,3/15/2021 5:25:03 PM
KURA,80 Biggest Movers From Yesterday,2/25/2021 10:57:48 AM
KURA,61 Stocks Moving In Wednesday's Mid-Day Session,2/24/2021 7:02:11 PM
KURA,"The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings",2/20/2021 3:36:28 PM
KURA,"Illumina announces strategic partnership with BMY, KURA, MYGN and Merck to advance comprehensive genomic profiling; provides 2021 guidance",1/11/2021 8:37:03 PM
KURA,Kura teams up with Illumina for a companion diagnostic for lead therapy,1/8/2021 9:34:52 PM
KURA,Kura Oncology to Participate in H.C. Wainwright BioConnect 2021 Conference,1/7/2021 1:30:00 PM
KURA,Kura Oncology to Present at J.P. Morgan Healthcare Conference,1/6/2021 1:30:00 PM
KURA,Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares,12/11/2020 10:05:00 PM
KURA,Kura Oncology to Participate in the JMP Securities Hematology Summit,12/10/2020 1:30:00 PM
KURA,Kura Oncology announces pricing of public offering,12/9/2020 2:24:55 PM
KURA,Kura Oncology Announces Commencement of Public Offering of Common Stock,12/7/2020 10:01:00 PM
KURA,Kura Oncology Presents First Clinical Data for Menin Inhibitor KO-539 at American Society of Hematology Annual Meeting,12/5/2020 6:30:00 PM
KURA,Seeking Alpha Catalyst Watch,12/4/2020 8:30:00 PM
KURA,"Kura Oncology to Host Virtual Investor Event on December 5, 2020",11/24/2020 1:30:00 PM
KURA,Kura Oncology Reports Third Quarter 2020 Financial Results,11/5/2020 1:30:00 PM
KURA,Kura Oncology down 15% on KO-539 safety signals in early-stage study,11/4/2020 2:04:34 PM
KURA,Kura Oncology to Report Third Quarter 2020 Financial Results,10/29/2020 12:30:10 PM
KURA,Kura Oncology Reports Preclinical Results Showing Antitumor Activity of Tipifarnib in Combination with PI3Kα Inhibitor in Head and Neck Squamous Cell Carcinoma,10/26/2020 12:30:10 PM
KURA,Kura Oncology Announces Preliminary Data for Menin Inhibitor KO-539 Accepted for Oral Presentation at ASH,10/7/2020 1:30:10 PM
KURA,Kura Oncology to Participate in Two Upcoming Investor Conferences,9/8/2020 1:30:10 PM
KURA,Kura Oncology Appoints Dr. Stephen Dale as Chief Medical Officer,8/25/2020 1:30:10 PM
KURA,Kura Oncology Reports Second Quarter 2020 Financial Results,8/6/2020 10:05:10 PM
KURA,Kura Oncology to Present at Wedbush PacGrow Healthcare Virtual Conference,8/4/2020 1:30:10 PM
KURA,Kura Oncology to Report Second Quarter 2020 Financial Results,7/30/2020 1:30:10 PM
KURA,Kura Oncology to Participate in JMP Securities Hematology & Oncology Forum,6/11/2020 1:30:10 PM
KURA,Kura Oncology Reports Overall Survival Data from Phase 2 Trial of Tipifarnib in HRAS Mutant Head and Neck Squamous Cell Carcinoma,5/29/2020 2:00:10 PM
KURA,Kura Oncology Announces Three Abstracts Accepted for Presentation at ASCO20 Virtual Scientific Program,5/13/2020 11:00:10 PM
KURA,Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares,5/8/2020 10:03:10 PM
KURA,Kura Oncology to Present at BofA Securities Virtual Health Care Conference 2020,5/7/2020 1:30:10 PM
KURA,Kura Oncology Announces Pricing of $125 Million Public Offering of Common Stock,5/6/2020 3:00:10 PM
KURA,Kura Oncology Announces Commencement of Public Offering of Common Stock,5/5/2020 10:01:10 PM
KURA,Kura Oncology Reports First Quarter 2020 Financial Results,5/4/2020 10:05:10 PM
KURA,Kura Oncology to Report First Quarter 2020 Financial Results,4/29/2020 1:30:10 PM
KURA,"NGL, GLOG, OXSQ and CINF among midday movers",4/28/2020 4:42:21 PM
KURA,Kura Oncology's tipifarnib Fast Track'd for T-cell lymphomas,3/3/2020 2:28:43 PM
KURA,Kura Oncology Reports Fourth Quarter and Full Year 2019 Financial Results,2/25/2020 10:03:00 PM
KURA,Kura Oncology to Participate in Three Upcoming Investor Conferences,2/19/2020 10:05:00 PM
KURA,Kura Oncology to Report Fourth Quarter and Full Year 2019 Financial Results,2/18/2020 10:05:00 PM
KURA,Kura Oncology Announces Transition of Chief Medical Officer,1/23/2020 10:05:00 PM
KURA,New FDA Approval Could Send Merck Higher,1/10/2020 2:29:13 PM
KURA,Kura Oncology to Present at J.P. Morgan Healthcare Conference,1/9/2020 1:30:00 PM
KURA,Kura Oncology Appoints Kirsten Flowers as Chief Commercial Officer,1/6/2020 1:30:00 PM
KURA,It’s Time to Add Some Portfolio Insurance,1/3/2020 2:30:58 PM
KURA,Kura Oncology Receives Fast Track Designation for Tipifarnib in HRAS Mutant HNSCC and Provides Enrollment Guidance for AIM-HN Trial,12/16/2019 1:30:00 PM
KURA,Kura Oncology Reports Clinical and Regulatory Updates for Tipifarnib in Angioimmunoblastic T-Cell Lymphoma,12/8/2019 6:00:00 PM
KURA,Kura Oncology to Participate in Piper Jaffray Healthcare Conference,11/26/2019 1:30:10 PM
KURA,Kura Oncology to Present at Stifel Healthcare Conference,11/12/2019 1:30:00 PM
KURA,Kura Oncology Announces Upcoming Presentation at ASH Annual Meeting,11/6/2019 3:06:25 PM
KURA,Kura Oncology Reports Third Quarter 2019 Financial Results and Provides Corporate Update,11/5/2019 10:05:00 PM
KURA,Kura Oncology Appoints James Basta as Chief Legal Officer,11/4/2019 1:30:00 PM
KURA,Kura Oncology to Report Third Quarter 2019 Financial Results,10/30/2019 12:30:05 PM
KURA,Kura Oncology Reports Durable Anti-Tumor Activity in Phase 2 Trial of Tipifarnib in HRAS Mutant Head and Neck Cancer,10/29/2019 4:50:05 PM
KURA,Kura Oncology Data Selected for Oral Presentation at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics,10/23/2019 10:05:05 PM
KURA,Kura Oncology Announces Upcoming Presentation at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics,10/16/2019 10:30:00 PM
KURA,Kura Oncology Expands Board of Directors with Appointment of Diane Parks,10/15/2019 1:30:00 PM
KURA,Kura Oncology Doses First Patient in Phase 1 Clinical Trial of Menin-MLL Inhibitor KO-539 in Acute Myeloid Leukemia,9/16/2019 1:30:00 PM
KURA,Kura Oncology Announces Positive Phase 2 Trial of Tipifarnib in HRAS Mutant Urothelial Carcinoma,9/3/2019 1:30:00 PM
KURA,Kura Oncology to Participate in Two Upcoming Investor Conferences,8/29/2019 1:30:00 PM
KURA,Kura Oncology Announces Appointment of Kathleen Ford as Chief Operating Officer,8/12/2019 10:05:00 PM
KURA,Kura Oncology to Present at Wedbush PacGrow Healthcare Conference,8/7/2019 1:30:00 PM
KURA,Kura Oncology Reports Second Quarter 2019 Financial Results and Provides Corporate Update,8/1/2019 10:05:00 PM
KURA,Kura Oncology to Report Second Quarter 2019 Financial Results ,7/25/2019 1:30:00 PM
KURA,Kura Oncology’s Menin-MLL Inhibitor KO-539 Receives Orphan Drug Designation from FDA for Treatment of Acute Myeloid Leukemia,7/24/2019 1:30:00 PM
KURA,Kura Oncology Expands Protection for Tipifarnib with New U.S. and European Patents,7/11/2019 1:30:00 PM
KURA,Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares,6/21/2019 10:30:00 PM
KURA,Kura Oncology Announces Pricing of $100 Million Public Offering of Common Stock,6/19/2019 5:31:09 AM
KURA,Kura Oncology Announces Commencement of Public Offering of Common Stock,6/18/2019 10:01:00 PM
KURA,Kura Oncology Announces Positive Phase 2 Trial of Tipifarnib in Peripheral T-Cell Lymphoma,6/14/2019 1:00:00 PM
KURA,Kura Oncology to Present at Bank of America Merrill Lynch Health Care Conference,5/8/2019 2:00:00 PM
KURA,Kura Oncology Reports First Quarter 2019 Financial Results and Highlights Upcoming Milestones,5/7/2019 10:05:00 PM
KURA,Kura Oncology to Report First Quarter 2019 Financial Results,4/30/2019 1:30:00 PM
KURA,"Kura Oncology Identifies Farnesylated Proteins Associated with CXCL12 Expression,  Potential Biomarker of Clinical Benefit from Tipifarnib in Lymphoma Indications",4/2/2019 10:04:00 PM
KURA,Kura Oncology to Participate in Two Upcoming Investor Conferences,3/6/2019 1:30:00 PM
KURA,Kura Oncology Reports Fourth Quarter and Full Year 2018 Financial Results,3/5/2019 10:03:00 PM
KURA,Kura Oncology to Report Fourth Quarter and Full Year 2018 Financial Results,2/26/2019 1:30:00 PM
KURA,Kura Oncology to Present at SVB Leerink Global Healthcare Conference,2/20/2019 1:30:00 PM
KURA,Kura Oncology Reports Clinical Activity of Tipifarnib in Subsets of Pancreatic Cancer Associated with High CXCL12 Expression,1/18/2019 4:00:00 PM
KURA,Kura Oncology to Present at J.P. Morgan Healthcare Conference,1/3/2019 1:30:00 PM
KURA,"XLRN On Watch, BPMC Makes An Imprint, Osteoporosis Drug Evenity Faces FDA Panel ",12/3/2018 6:07:04 AM
KURA,"Kura Oncology Announces Proof of Concept in Angioimmunoblastic T-Cell Lymphoma, Validation of CXCL12 as a Therapeutic Target of Tipifarnib in Peripheral T-Cell Lymphoma",12/2/2018 6:00:00 PM
KURA,Kura Oncology Announces New Patent for Tipifarnib in Angioimmunoblastic T-Cell Lymphoma,11/28/2018 1:30:00 PM
KURA,Kura Oncology Adds Commercial Veteran Mary Szela to Board of Directors,11/8/2018 1:30:00 PM
KURA,Kura Oncology to Participate in Two Upcoming Investor Conferences,11/6/2018 1:30:00 PM
KURA,Kura Oncology Reports Third Quarter 2018 Financial Results and Provides Corporate Update,11/5/2018 10:05:00 PM
KURA,Kura Oncology Announces Upcoming Presentations at ASH Annual Meeting,11/1/2018 2:00:00 PM
KURA,Kura Oncology to Report Third Quarter 2018 Financial Results,10/29/2018 12:30:00 PM
KURA,Kura Oncology Presents Update on Positive Phase 2 Trial of Tipifarnib in HRAS Mutant HNSCC and Preliminary Results in HRAS Mutant SCC,10/22/2018 2:45:00 PM
KURA,Kura Oncology to Present at Leerink Partners Rare Disease & Oncology Roundtable,9/26/2018 10:05:00 PM
KURA,Kura Oncology to Present at H.C. Wainwright Global Investment Conference,8/30/2018 1:30:00 PM
KURA,Kura Oncology to Present at 2018 Wedbush PacGrow Healthcare Conference,8/7/2018 10:05:00 PM
KURA,Kura Oncology Reports Second Quarter 2018 Financial Results and Provides Corporate Update,8/6/2018 10:05:00 PM
KURA,"Kura Oncology Appoints Marc Grasso, M.D., as Chief Financial Officer and Chief Business OfficerInvestment banking veteran brings two decades of experience in finance and corporate strategy in the...",7/31/2018 1:30:00 PM
KURA,Kura Oncology to Report Second Quarter 2018 Financial Results,7/30/2018 10:05:00 PM
KURA,Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares,7/2/2018 10:30:00 PM
KURA,Kura Oncology Announces Pricing of $67 Million Public Offering of Common Stock,6/28/2018 1:30:00 PM
KURA,Kura Oncology Announces Commencement of Public Offering of Common Stock,6/27/2018 10:01:00 PM
KURA,"Kura Oncology Appoints Chief Operating Officer, Expands Clinical Development Team as Company Prepares for First Registration-Directed Trial",6/20/2018 1:30:00 PM
KURA,Kura Oncology to Present at JMP Securities Life Sciences Conference,6/14/2018 1:30:00 PM
KURA,OncoDNA announces screening collaboration with Kura Oncology,5/22/2018 1:00:00 PM
KURA,Kura Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update,5/8/2018 10:05:00 PM
KURA,Kura Oncology to Present at Deutsche Bank 43rd Annual Health Care Conference,5/3/2018 1:30:00 PM
KURA,BRIEF-Kura Oncology Announces New Patent For Tipifarnib In Hematologic Malignancies,5/2/2018 1:39:03 PM
KURA,Kura Oncology to Report First Quarter 2018 Financial Results,5/1/2018 1:30:00 PM
KURA,Kura Oncology Announces Upcoming Presentations at AACR Annual Meeting 2018,4/9/2018 1:30:00 PM
KURA,Kura Oncology to Present at Oppenheimer 28th Annual Healthcare Conference,3/16/2018 12:30:00 PM
KURA,Kura Oncology Provides Regulatory Update on Tipifarnib and Reports Fourth Quarter and Full Year 2017 Financial Results,3/12/2018 9:05:00 PM
KURA,Kura Oncology to Present at Cowen and Company 38th Annual Health Care Conference,3/6/2018 1:30:00 PM
KURA,Kura Oncology to Report Fourth Quarter and Full Year 2017 Financial Results,3/5/2018 10:05:00 PM
KURA,"FDA To Decide On APRI's ED Drug, KURA Nails It, MBRX Dynamic, GLMD Awaits ARREST ",2/16/2018 2:16:42 AM
KURA,Kura Oncology Provides Update on Phase 2 Trial of Tipifarnib in HRAS Mutant Head and Neck Cancer,2/15/2018 5:00:00 PM
KURA,Will These 4 Pharma Stocks Be Loved Or Dumped This Month? ,2/12/2018 11:55:58 AM
KURA,Kura Oncology to Present at the Leerink Partners 7th Annual Global Healthcare Conference,2/8/2018 1:30:00 PM
KURA,"CARA Abuzz, CERS Up 20% In 5 Days, KURA Turns Heads, JNCE Making Iconic Moves ",1/25/2018 1:41:17 AM
KURA,Kura Oncology Added to Nasdaq Biotechnology Index,12/18/2017 1:30:00 PM
KURA,Kura Oncology Identifies Potential Biomarkers of Activity for Lead Candidate Tipifarnib in Bone Marrow Cancers,12/11/2017 4:00:00 PM
KURA,Kura Oncology Reports Positive Phase 2 Study of Tipifarnib in Chronic Myelomonocytic Leukemia,12/10/2017 3:00:00 PM
KURA,"ASH: Here's Why You Need To Keep An Eye On ARGX, MGNX, KURA, AGIO ",12/4/2017 7:46:39 AM
KURA,"SAGE Goes Out On A High Note, MRNS Spirited, STAAR Shines, OPK Slumps ",11/10/2017 3:24:45 AM
KURA,"Kura Oncology to Host Investor Day on November 16, 2017",11/9/2017 10:05:00 PM
KURA,Kura Oncology Reports Third Quarter 2017 Financial Results and Provides Corporate UpdateManagement to host webcast and conference call today at 4:30 p.m. ET,11/7/2017 10:05:00 PM
KURA,Kura Oncology Announces Upcoming Presentations at American Society of Hematology Annual Meeting,11/1/2017 9:05:00 PM
KURA,Kura Oncology to Report Third Quarter 2017 Financial Results,10/31/2017 9:05:00 PM
KURA,"FDA To Rule On Elagolix In Q2, More Light From CELG's RADIANCE, TGTX On Watch ",10/30/2017 4:00:28 AM
KURA,"Kura: KO-539 Shows Preclinical Anti-Tumor Activity In NPM1, DNMT3A Mutant AML ",10/28/2017 7:43:35 PM
KURA,Kura Oncology Lead Candidate Tipifarnib Shows Durable Anti-Tumor Activity in HRAS Mutant Head and Neck Cancer in AACR-NCI-EORTC Update,10/27/2017 4:50:00 PM
KURA,Kura Oncology Announces Late-Breaking Presentations for Tipifarnib in HRAS Mutant Squamous Head and Neck Cancer and for KO-539 in AML at Upcoming AACR-NCI-EORTC International Conference,10/16/2017 1:30:00 PM
KURA,"Keep An Eye On These Biotech Stocks This Month, If Invested ",9/18/2017 9:14:09 AM
KURA,HALO Just Got Brighter - What Other Pharma Stocks Made News This Week? ,9/15/2017 8:11:30 AM
KURA,"Christmas Comes Early For KURA, ANTH On Track, ABBV Hits All-time High ",9/8/2017 8:46:56 AM
KURA,Kura Oncology Announces Positive Phase 2 Study for Tipifarnib in HRAS Mutant Head and Neck Cancer,9/7/2017 10:05:00 PM
KURA,"Gainers & Losers Of Aug.16: XENE, JNCE, MYOK, ADMS, LIFE... ",8/17/2017 3:21:09 AM
KURA,Kura Oncology Moves To Downside After Pricing Public Stock Offering ,8/11/2017 8:22:11 PM
KURA,"Gainers & Losers Of Aug.8: FGEN, CUTR, ESPR, DEPO, DERM... ",8/9/2017 4:41:19 AM
KURA,"Gainers & Losers Of June 19: ARNA, NVDQ, CLVS, RWLK, CLSN... ",6/20/2017 2:51:59 AM
KURA,"Gainers & Losers Of Mar.7: AUPH, KURA, TEAR, AXSM, AKBA... ",3/8/2017 3:48:52 AM
KURA,"Gainers & Losers Of Mar.6: TGTX, CNCE, DXTR, KURA, ARGS... ",3/7/2017 2:00:36 AM
KURA,"Gainers & Losers Of Feb.28: KITE, PBMD, LIFE, VRX, PRGO... ",3/1/2017 4:51:48 AM
KURA,"Gainers & Losers Of Feb.27: LJPC, NVAX, KTOV, CYCC, ARGS... ",2/28/2017 4:24:28 AM
